[1] Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia[J]. Obstet Gynecol,2008,112:359-372. [2] Hjartardottir S, Leifsson BG, Geirsson RT, et al.Recurrence of hypertensive disorder in second pregnancy[J]. Am J Obstet Gynecol,2006,194:916-920.[3] Brown MA, Mackenzie C, Dunsmuir W, et al. Can we predict recurrence of preeclampsia or gestational hypertension? [J].BJOG,2007,114:984-993.[4] Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia[J]. Am J Obstet Gynecol,2009,200:481.e1-7.[5] Sibai BM, Lindheimer M, Hauth J,et al.Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units[J]. N Engl J Med,1998,339:667-671.[6] Vanek M, Sheiner E, Levy A, et al. Chronic hypertension and the risk for adverse pregnancy outcome after superimposed preeclampsia[J]. Int J Gynaecol Obstet,2004,86:7-11.[7] Nakhai-Pour HR, Rey E, Berard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns[J]. Birth Defects Res B Dev Reprod Toxicol,2010,89:147-154.[8] Abalos E, Duley L, Steyn DW, et al. Anti- hypertensive drug therapy for mild to moderate hyper- tension during pregnancy[J]. Cochrane Database Syst Rev,2007,(1): CD002252. DOI:10.1002/14651858.CD002252.pub2.[9] Sibai BM, Mabie WC, Shamsa F, et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy[J]. Am J Obstet Gynecol,1990,162:960-966[10] Laube GF, Kemper MJ, Schubiger G, et al. Angiotensin-converting enzyme inhibitor fetopathy: long-term outcome[J]. Arch Dis Child Fetal Neonatal Ed,2007,92: F402-F403.[11] Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors[J]. N Engl J Med ,2006,354:2443-2451.[12] Hutcheon JA, Lisonkova S, Magee LA, et al. Optimal timing of delivery in pregnancies with pre-existing hypertension[J]. BJOG, 2011,118:49-54.[13] Tuuli MG, Rampersad R, Stamilio D, et al. Perinatal outcomes in women with preeclampsia and superimposed preeclampsia: do they differ? [J].Am J Obstet Gynecol,2011,204:508.e1-7.[14] Sibai BM. Evaluation and management of severe pre- eclampsia before 34 weeks' gestation. Publications Committee, Society for Maternal-Fetal Medicine[J]. Am J Obstet Gynecol,2011,205:191-198.[15] Chames MC, Livingston JC, Ivester TS, et al. Late postpartum eclampsia: a preventable disease? [J].Am J Obstet Gynecol,2002,186:1174-1177.[16] Saudan P, Brown MA, Buddle ML, et al. Does gestational hypertension become preeclampsia? [J].Br J Obstet Gynaecol,1998,105:1177-1184.(2014-07-10收稿) |